These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Heterologous gam-COVID-vac (sputnik V)/mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysis. Pereson MJ; Amaya L; Neukam K; Baré P; Echegoyen N; Badano MN; Lucero A; Martelli A; Garcia GH; Videla C; Martínez AP; Di Lello FA Clin Microbiol Infect; 2022 Oct; 28(10):1382-1388. PubMed ID: 35595128 [TBL] [Abstract][Full Text] [Related]
4. Comparison of immune activation of the COVID vaccines: ChAdOx1, BNT162b2, mRNA-1273, BBIBP-CorV, and Gam-COVID-Vac from serological human samples in Hungary showed higher protection after mRNA-based immunization. Fodor E; Olmos Calvo I; Kuten-Pella O; Hamar E; Bukva M; Madár Á; Hornyák I; Hinsenkamp A; Hetényi R; Földes F; Brigitta Z; Jakab F; Kemenesi G; Lacza Z Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5297-5306. PubMed ID: 35916830 [TBL] [Abstract][Full Text] [Related]
7. BNT162b2, mRNA-1273, and Sputnik V Vaccines Induce Comparable Immune Responses on a Par With Severe Course of COVID-19. Kaznadzey A; Tutukina M; Bessonova T; Kireeva M; Mazo I Front Immunol; 2022; 13():797918. PubMed ID: 35493476 [TBL] [Abstract][Full Text] [Related]
8. Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination. Sheng WH; Chang SY; Lin PH; Hsieh MJ; Chang HH; Cheng CY; Yang HC; Pan CF; Ieong SM; Chao TL; Chen JP; Cheng SH; Chang SC J Formos Med Assoc; 2022 Apr; 121(4):766-777. PubMed ID: 35305895 [TBL] [Abstract][Full Text] [Related]
9. Reactivation of a BCG Vaccination Scar Following the First Dose of the Moderna COVID-19 Vaccine. Tao J; Rosenfeld D; Hsu J; Bhatia A Cutis; 2022 Mar; 109(3):148-149. PubMed ID: 35659140 [TBL] [Abstract][Full Text] [Related]
10. Presence and quantity of antibodies after vaccination «Gam-COVID-Vac». Petrova OV; Tverdokhlebova DK Klin Lab Diagn; 2022 Mar; 67(3):147-150. PubMed ID: 35320629 [TBL] [Abstract][Full Text] [Related]
11. Elevated Clozapine Blood Concentrations After Second COVID-19 Vaccination With Spikevax (COVID-19 Vaccine Moderna). Knöchel C; Hefner G; Stiehl T; Schmidbauer W J Clin Psychopharmacol; 2022 May-Jun 01; 42(3):317-320. PubMed ID: 35091524 [No Abstract] [Full Text] [Related]
12. Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignancies. Tsimafeyeu I; Volkova M; Alekseeva G; Berkut M; Nosov A; Myslevtsev I; Andrianov A; Semenov A; Borisov P; Zukov R; Goutnik V; Savchuk S; Dengina N; Mitin T J Hematol Oncol; 2021 Nov; 14(1):192. PubMed ID: 34774086 [TBL] [Abstract][Full Text] [Related]
13. Cutaneous arteritis following mRNA-1273 Moderna COVID-19 vaccination. Ogawa T; Aitake U; Nomura T J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e399-e400. PubMed ID: 35066922 [No Abstract] [Full Text] [Related]
14. ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance. Di Valerio Z; La Fauci G; Soldà G; Montalti M; Lenzi J; Forcellini M; Barvas E; Guttmann S; Poluzzi E; Raschi E; Riccardi R; Fantini MP; Salussolia A; Gori D EClinicalMedicine; 2022 Jul; 49():101468. PubMed ID: 35614901 [TBL] [Abstract][Full Text] [Related]
15. COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a preliminary assessment from a case-control study in St. Petersburg, Russia. Barchuk A; Bulina A; Cherkashin M; Berezina N; Rakova T; Kuplevatskaya D; Stanevich O; Skougarevskiy D; Okhotin A BMC Public Health; 2022 Sep; 22(1):1803. PubMed ID: 36138385 [TBL] [Abstract][Full Text] [Related]
16. Features of the humoral response to immunization "Gam-COVID-Vac" and in patients with COVID-19. Akinshina YA; Mardanly SG; Rotanov SV; Pomazanov VV; Kiseleva VA; Ermolaev III Klin Lab Diagn; 2022 Apr; 67(4):227-233. PubMed ID: 35575396 [TBL] [Abstract][Full Text] [Related]
17. Pharmacist-directed Sputnik V (GAM-COVID-VAC) surveillance program: a prospective observational study in Southern India. Karattuthodi MS; Chandrasekher D; Panakkal LM; C S; Salman M; Megha ; E MS; Fasil M; A M M; Reji M J Basic Clin Physiol Pharmacol; 2023 Jul; 34(4):509-517. PubMed ID: 35172420 [TBL] [Abstract][Full Text] [Related]
18. Gam-COVID-Vac, EpiVacCorona, and CoviVac effectiveness against lung injury during Delta and Omicron variant surges in St. Petersburg, Russia: a test-negative case-control study. Barchuk A; Bulina A; Cherkashin M; Berezina N; Rakova T; Kuplevatskaya D; Skougarevskiy D; Okhotin A Respir Res; 2022 Oct; 23(1):276. PubMed ID: 36217139 [TBL] [Abstract][Full Text] [Related]
20. ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance. Montalti M; Soldà G; Di Valerio Z; Salussolia A; Lenzi J; Forcellini M; Barvas E; Guttmann S; Messina R; Poluzzi E; Raschi E; Riccardi R; Fantini MP; La Fauci G; Gori D; EClinicalMedicine; 2021 Aug; 38():101027. PubMed ID: 34505029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]